Should I buy Abrdn shares just for the 5% dividend yield?

Abrdn shares pay an attractive income amount. But should I buy the stock just for the dividend? Here I take a closer look at the company.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Risk reward ratio / risk management concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Abrdn (LSE: ABDN) shares are currently yielding 5%. As an income-hungry investor, this is certainly attractive. What’s more, the stock is dirt-cheap. It has a current price-to-earnings (P/E) ratio of 8x.

But as much as the income is appealing, should I buy Abrdn shares just for the dividend yield? In short, I wouldn’t. I don’t think the investment case for a stock can solely be based on the income. In my opinion, the underlying business should be displaying some growth as well.

A lot of things are happening at the asset manager right now. So I’ve place it on my watch list. Here’s why.

Change

The fund manager was formed through a 2017 merger of Standard Life and Aberdeen Asset Management. But since then, things haven’t been great.

There’s been a lot of change at the company. The firm was formerly known as Standard Life Aberdeen but it has been rebranded to Abrdn, a move that attracted a lot of critical comment.

Stephen Bird, the new CEO took over the role last September. He’s trying to turn around the company. So far he has carried out the rebranding to improve the firm’s clarity and focus.  He has also put in place a new management team, which could drive and improve the growth of each division. Bird is also implementing costs savings and is simplifying the business by selling non-core assets.

This is all well and good. But will it result in higher revenues and profits? It’s still very early days for the strategy, too early to assess its progress. But it could work and I’ll certainly be watching Abdrn’s transformation closely.

Results

Abrdn shares took over a 2% hit yesterday after it released its half-year results. Fee-based revenue improved by 7% compared to last year. But it still suffered £5.6bn of net outflows. This was a slowdown compared to the total outflows of £24.8bn in the first half of 2020.

Funds under management are key for the firm. But outflows have been a persistent problem since the merger. Abrdn needs to convince its clients that its funds are the best place to park their money. And the only way it’s going to do this is by improving the investment performance of its products.

If Abrdn can’t do this then its clients will invest with another asset manager. And the industry is extremely competitive.

Dividend

As I said before, the appealing thing about Abrdn shares is the dividend. But my concern is that the income isn’t covered by profits. And if the firm is still suffering from fund outflows, this could impact any future payments.

Abrdn is focused on building returns for shareholders. But it has rebased the annual dividend to 14.6p and will grow it when the income is “1.5x covered by adjusted capital generation”. In a nutshell, this isn’t going to happen any time soon.

Should I buy?

The stock is on my watch list. Abrdn’s turnaround won’t happen overnight. And it needs to fix its investment performance to reduce fund outflows. Until I see evidence of this, I’m not buying the shares just for the income.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Nadia Yaqub has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »